Detalhe da pesquisa
1.
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV.
Haematologica
; 104(5): 955-962, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30514803
2.
Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV.
Ann Hematol
; 93(1): 71-80, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24162333
3.
Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CML.
Leukemia
; 34(10): 2823, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32913312
4.
High-risk additional chromosomal abnormalities at low blast counts herald death by CML.
Leukemia
; 34(8): 2074-2086, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32382082
5.
DNA methylation profile of a hepatosplenic gamma/delta T-cell lymphoma patient associated with response to interferon-α therapy.
Cell Mol Immunol
; 18(5): 1332-1335, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32820235
6.
Myeloablative radiochemotherapy followed by autologous peripheral blood stem cell transplantation as first-line therapy in peripheral T-cell lymphomas: first results of a prospective multicenter study.
Hematol J
; 5(4): 304-11, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15297846
7.
Explaining survival differences between two consecutive studies with allogeneic stem cell transplantation in patients with chronic myeloid leukemia.
J Cancer Res Clin Oncol
; 140(8): 1367-81, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24718719
8.
Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib: results from the randomized CML-study IV.
J Clin Oncol
; 32(5): 415-23, 2014 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24297946
9.
Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-α in newly diagnosed chronic myeloid leukemia.
J Clin Oncol
; 29(12): 1634-42, 2011 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-21422420
10.
Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 trial of the German Hodgkin Study Group.
J Clin Oncol
; 29(32): 4234-42, 2011 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-21990399
11.
Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study.
J Clin Oncol
; 27(1): 106-13, 2009 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19029417
12.
Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia.
Blood
; 109(11): 4686-92, 2007 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17317858
13.
The CD19+ B-cell counts at peripheral blood stem cell mobilization determine different levels of tumour contamination and autograft purgability in low-grade lymphoma.
Br J Haematol
; 116(3): 695-701, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11849235